Skip to content
Screener

Cue Biopharma CUE Q2 2025 earnings

Reported August 12, 2025 · Before market open

Revenue$3.0MBeat by $664.3K
EPS-$0.09Beat by $0.04
Revenue estimate$2.3M
EPS estimate-$0.13

Next report

Nov 11, 2026 (In 1 week)
Revenue estimate$1.0M
EPS estimate-$2.24

FAQ

When did Cue Biopharma report Q2 2025 earnings?
Cue Biopharma (CUE) reported Q2 2025 earnings on August 12, 2025 before market open.
What were Cue Biopharma's Q2 2025 revenue and EPS?
Cue Biopharma reported revenue of $3.0M and eps of $-0.09 for Q2 2025.
Did Cue Biopharma beat estimates in Q2 2025?
Revenue beat the consensus estimate of $2.3M by $664.3K. EPS beat the consensus estimate of $-0.13 by $0.04.
How did Cue Biopharma's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.1% from $2.7M a year earlier and eps grew 55.0% from $-0.20.
Where can I find Cue Biopharma's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-107268) and the 10-Q periodic report (0000950170-25-107270) directly on SEC EDGAR. The filing index links above go to sec.gov.